| Primary |
| Product Used For Unknown Indication |
55.8% |
| Drug Exposure During Pregnancy |
10.5% |
| Contraception |
8.1% |
| Acute Myeloid Leukaemia |
3.5% |
| Diabetes Mellitus |
3.5% |
| Myelodysplastic Syndrome |
3.5% |
| Exposure During Breast Feeding |
2.3% |
| Haemorrhage |
2.3% |
| Schizophrenia |
2.3% |
| Drug Use For Unknown Indication |
1.2% |
| Epilepsy |
1.2% |
| Hypertension |
1.2% |
| Menorrhagia |
1.2% |
| Menstrual Disorder |
1.2% |
| Oestrogen Therapy |
1.2% |
| Vaginal Haemorrhage |
1.2% |
|
| Abortion Spontaneous |
5.0% |
| Alanine Aminotransferase Increased |
5.0% |
| Breast Feeding |
5.0% |
| Death |
5.0% |
| Exposure During Breast Feeding |
5.0% |
| Headache |
5.0% |
| Hepatitis Acute |
5.0% |
| Malaise |
5.0% |
| Maternal Exposure During Pregnancy |
5.0% |
| Mood Altered |
5.0% |
| Nausea |
5.0% |
| Oedema Peripheral |
5.0% |
| Pregnancy On Contraceptive |
5.0% |
| Pregnancy On Oral Contraceptive |
5.0% |
| Premature Labour |
5.0% |
| Product Packaging Quantity Issue |
5.0% |
| Rash Pruritic |
5.0% |
| Speech Disorder |
5.0% |
| Spina Bifida |
5.0% |
| Ventricular Septal Defect |
5.0% |
|
| Secondary |
| Product Used For Unknown Indication |
19.4% |
| Idiopathic Thrombocytopenic Purpura |
10.8% |
| Haematology Test Abnormal |
9.0% |
| Gastrooesophageal Reflux Prophylaxis |
8.8% |
| Antiemetic Supportive Care |
8.4% |
| Pain |
5.2% |
| Hypertension |
5.1% |
| Hormone Replacement Therapy |
4.6% |
| Blood Cholesterol |
4.5% |
| Menstrual Disorder |
4.5% |
| Diabetes Mellitus |
4.4% |
| Mental Disorder |
4.4% |
| Smoking Cessation Therapy |
2.4% |
| Endometriosis |
2.1% |
| Autoimmune Thrombocytopenia |
1.5% |
| Acute Myeloid Leukaemia |
1.4% |
| Myelodysplastic Syndrome |
1.2% |
| Drug Exposure During Pregnancy |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Menorrhagia |
0.8% |
|
| Withdrawal Syndrome |
24.5% |
| Vaginal Haemorrhage |
8.8% |
| Breast Cancer |
7.5% |
| Rectal Haemorrhage |
7.5% |
| Purpura |
6.3% |
| Rash Maculo-papular |
6.3% |
| Haemorrhage |
5.0% |
| Breast Cancer Metastatic |
4.4% |
| Haemoglobin Decreased |
4.4% |
| Rash Erythematous |
4.4% |
| Venoocclusive Disease |
3.8% |
| Abortion Spontaneous |
3.1% |
| Blood Blister |
2.5% |
| Melaena |
2.5% |
| Arthralgia |
1.9% |
| Weight Increased |
1.9% |
| Alanine Aminotransferase Increased |
1.3% |
| Hepatotoxicity |
1.3% |
| Idiopathic Thrombocytopenic Purpura |
1.3% |
| Liver Function Test Abnormal |
1.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.7% |
| Endometriosis |
13.2% |
| Pain |
4.4% |
| Prophylaxis |
4.2% |
| Prophylaxis Of Nausea And Vomiting |
4.2% |
| Contraception |
3.4% |
| Hormone Replacement Therapy |
3.3% |
| Uterine Leiomyoma |
2.7% |
| Drug Use For Unknown Indication |
2.6% |
| Rheumatoid Arthritis |
2.2% |
| Anxiety |
1.8% |
| Haematology Test Abnormal |
1.7% |
| Acute Lymphocytic Leukaemia |
1.6% |
| Colitis Ulcerative |
1.6% |
| Smoking Cessation Therapy |
1.6% |
| Asthma |
1.5% |
| Hypertension |
1.5% |
| Back Pain |
1.4% |
| Depression |
1.3% |
| Oral Contraception |
1.3% |
|
| Hot Flush |
9.7% |
| Vaginal Haemorrhage |
9.7% |
| Vomiting |
9.1% |
| Weight Increased |
7.8% |
| Pulmonary Embolism |
5.8% |
| Depression |
5.2% |
| Weight Decreased |
5.2% |
| Migraine |
4.5% |
| Nausea |
4.5% |
| Urinary Tract Infection |
4.5% |
| Anal Cancer |
3.9% |
| Muscle Spasms |
3.9% |
| Pain |
3.9% |
| Rash |
3.9% |
| Tonsillitis |
3.9% |
| Headache |
3.2% |
| Thrombosis |
3.2% |
| Abdominal Pain |
2.6% |
| Menstruation Irregular |
2.6% |
| Proctalgia |
2.6% |
|
